I migliori medici per il trattamento di Rabdomiosarcoma - TOP-28 medici

Il Professore Associato Muhammet Derda Ozer ha eseguito oltre 25.000 procedure e si specializza nei casi di rabdomiosarcoma oftalmico pediatrico presso DERDA SAGLIK HIZMETLERI.

• 21 anni di esperienza in oftalmologia con un focus sull'oncologia oculare
• ICO-STAAR Surgical Fellow in Vitreo-Retina presso l'Università del Kansas
• Ha presentato ricerche sul rabdomiosarcoma in congressi nazionali di oftalmologia
• Membro attivo della Società Oftalmologica Turca

Specializzato in oncologia dei tessuti molli e delle ossa da oltre 25 anni, il Prof. Merimsky dirige l'unità sarcoma presso il Sourasky Medical Center.

• Formazione di fellowship in sarcomi presso l'Institut Gustave Roussy, Parigi
• Membro della facoltà ESMO per i sarcomi dei tessuti molli e delle ossa
• Ha diretto il dipartimento di oncologia dell'Università di Tel-Aviv
• Ha pubblicato ampie ricerche su tumori ossei e dei tessuti molli

Il medico è il capo del Dipartimento di Oncoematologia e Oncologia Pediatrica presso l'Ospedale Pediatrico Dana Dwek. Specializzandosi in trapianti di midollo osseo e sangue del cordone ombelicale per bambini, il medico ha effettuato oltre 300 trapianti. Con una forte presenza accademica, il medico ha pubblicato 50 articoli e presentato 40 relazioni in varie conferenze mediche. Il medico è membro dell'Associazione Americana di Ematologia e della Società Israeliana di Emato-oncologia Pediatrica, e ha praticato presso il City of Hope Hospital di Los Angeles e in vari centri medici in Israele.<\/p>

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.

• Member of the International Society of Pediatric Oncology (SIOP).
• Active member of the European Bone Marrow Transplant Group (EBMT).
• Published more than 40 articles on stem cell therapy and blood disorders.
• Works at a center performing the highest number of transplants in Turkey.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>

Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>

La professoressa Yesim Yildirim ha scritto più di 80 pubblicazioni internazionali e capitoli di libri specializzati nella cura del cancro. Guida con un focus sulle nuove immunoterapie oncologiche e terapie mirate.

• Specializzata nel trattamento dei tumori della mammella, gastrointestinali e polmonari
• Più di un decennio di esperienza presso l'Anadolu Medical Center
• Professoressa di oncologia medica all'Università di Halic a Istanbul
• Possiede un certificato di attestazione della Società Europea di Oncologia Medica (ESMO)
• Ha completato una formazione avanzata presso centri di eccellenza in Israele e nel Regno Unito

Il medico è un esperto leader in ematologia e oncologia pediatrica, specializzato in disturbi del sangue e cancro osseo (sarcoma) nei bambini. Attualmente, il medico è direttore del dipartimento di ematologia oncologica pediatrica presso il Sourasky Medical Center di Tel Aviv ed è un pediatra senior presso il Dana Children's Hospital. Il medico coordina il trattamento del cancro osseo e del sarcoma dei tessuti molli, gestisce i disturbi della coagulazione del sangue e supervisiona l'ematologia nei neonati prematuri. Il medico è membro dell'Associazione Israeliana di Emato-Oncologia Pediatrica (ISPHO).

Il medico si è laureato presso l'Università Ben-Gurion e si è specializzato in medicina pediatrica presso il Kaplan Medical Center, con ulteriore specializzazione in ematologia e oncologia pediatrica presso il Schneider Children's Medical Center. Ulteriore formazione è stata completata in oncologia ossea e dei tessuti molli presso l'Istituto Ortopedico Rizzoli in Italia.

Dr. Nichakorn Seehirunwong is a diagnostic radiologist at Intrarat Hospital in Bangkok. She specializes in interpreting medical imaging results and informing complex treatment plans. Dr. Seehirunwong earned her medical degree from the Prince of Songkla University. She also completed her diagnostic radiology certification at the same institution.

• Performs imaging-guided procedures and radiation oncology treatments.
• Treats pediatric oncology cases including neuroblastoma and Wilms tumor.
• Provides diagnostic support for brain tumors, sarcomas, and lymphomas.
• Works at Intrarat Hospital, an ISO 9001:2015-certified facility in Thailand.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Il medico è un oncochirurgo altamente qualificato con vasta esperienza in oncologia chirurgica. Specializzandosi nel trattamento di casi complessi di cancro, ha eseguito con successo numerosi interventi oncologici avanzati. Il medico è riconosciuto per la sua competenza nelle tecniche minimamente invasive, contribuendo a migliorare i risultati dei pazienti e i tempi di recupero. Con un impegno per la ricerca e l'innovazione, ha pubblicato diversi articoli influenti su riviste mediche di primo piano. Il medico è anche attivamente coinvolto in studi clinici mirati allo sviluppo di trattamenti oncologici all'avanguardia.<\/p>

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Il medico è direttore della divisione pediatrica presso l'Ospedale Pediatrico Ruth Rappaport (Rambam) ed è un esperto riconosciuto a livello mondiale in oncologia pediatrica e trapianto di midollo osseo.<\/p>

Riconosciuto per i contributi eccezionali nel campo, il medico ha ricevuto il Premio del Ministero della Salute e il titolo di Cavaliere della Legion d'Onore in Francia. Inoltre, è stato riconosciuto dall'Associazione Medica Mondiale come uno dei medici più premurosi al mondo.<\/p>

Attivo nelle comunità mediche internazionali, il medico è membro del gruppo di oncologia pediatrica negli USA e di varie società europee di oncologia.<\/p>

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.